Загрузка...
Successful response to first-line treatment with osimertinib for choroidal metastasis from EGFR-mutated non-small-cell lung cancer
Purpose: Describe the use of osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, as the first-line treatment in a patient with choroidal and central nervous system metastases from EGFR-mutated non-small cell lung cancer. Observations: A 68-year-old man...
Сохранить в:
Главные авторы: | , , , |
---|---|
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
Elsevier
2022-06-01
|
Серии: | American Journal of Ophthalmology Case Reports |
Предметы: | |
Online-ссылка: | http://www.sciencedirect.com/science/article/pii/S2451993622002055 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|